← All Companies
Transcode Therapeutics, Inc.
RNAZ · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary Overview TransCode is an RNA oncology company created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics. For decades, ribonucleic acid, or RNA, has been a topic of investigation by the scientific community as a potentially attractive therapeutic modality because it can target any gene and it lends itself to rational and straightforward drug design. RNA-based therapeutics are highly selective to their targets, potentially making av...
Next Earnings Q2 FY2026 — expected 2026-09-01
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention RNAZ discussed_in_filing Cybersecurity topic_mention RNAZ discussed_in_filing Trusted Computing topic_mention RNAZ discussed_in_filing Blockchain & Crypto topic_mention RNAZ discussed_in_filing Regulation topic_mention RNAZ discussed_in_filing Automotive topic_mention RNAZ discussed_in_filing Healthcare & Bio topic_mention RNAZ discussed_in_filing Platform & Ecosystem topic_mention RNAZ discussed_in_filing Cybersecurity topic_mention RNAZ discussed_in_filing Trusted Computing topic_mention RNAZ discussed_in_filing Blockchain & Crypto topic_mention RNAZ discussed_in_filing Regulation topic_mention RNAZ discussed_in_filing Automotive topic_mention RNAZ discussed_in_filing Healthcare & Bio topic_mention RNAZ discussed_in_filing Platform & Ecosystem topic_mention RNAZ discussed_in_filing Cybersecurity topic_mention RNAZ discussed_in_filing Trusted Computing topic_mention RNAZ discussed_in_filing Blockchain & Crypto topic_mention RNAZ discussed_in_filing Regulation topic_mention RNAZ discussed_in_filing Automotive topic_mention RNAZ discussed_in_filing Healthcare & Bio
Annual Reports (10-K) Filed Period Accession Source Full Text 2025-04-15 2024-12-31 0001558370-25-004843 EDGAR 112K words 2024-04-01 2023-12-31 0001410578-24-000413 EDGAR — 2023-03-31 2022-12-31 0001104659-23-040158 EDGAR — 2022-03-31 2021-12-31 0001104659-22-040778 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-14 2025-09-30 0001829635-25-000004 EDGAR 38K words 2025-08-14 2025-06-30 0001558370-25-011571 EDGAR — 2025-05-14 2025-03-31 0001558370-25-007759 EDGAR — 2024-11-14 2024-09-30 0001558370-24-015731 EDGAR — 2024-08-14 2024-06-30 0001558370-24-012264 EDGAR — 2024-05-15 2024-03-31 0001558370-24-008298 EDGAR — 2023-11-14 2023-09-30 0001410578-23-002489 EDGAR — 2023-08-14 2023-06-30 0001410578-23-001892 EDGAR — 2023-05-15 2023-03-31 0001104659-23-060810 EDGAR — 2022-11-14 2022-09-30 0001104659-22-118641 EDGAR — 2022-08-15 2022-06-30 0001104659-22-091201 EDGAR — 2022-05-16 2022-03-31 0001104659-22-060806 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-03 0001104659-26-022830 EDGAR 6K words 2026-02-23 0001104659-26-018362 EDGAR — 2026-02-05 0001104659-26-010668 EDGAR — 2026-01-06 0001104659-26-001097 EDGAR — 2025-12-22 0001104659-25-123500 EDGAR — 2025-12-11 0001104659-25-120146 EDGAR — 2025-10-27 0001104659-25-102361 EDGAR — 2025-10-14 0001104659-25-099029 EDGAR — 2025-10-08 0001104659-25-097799 EDGAR — 2025-10-03 0001104659-25-096658 EDGAR —
129 total filings indexed. 103 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001829635
Ticker RNAZ
Exchange Nasdaq
SIC 2834: Pharmaceutical Preparations
Incorporated DE
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: f9cca5ec520a0bd60570b371e168c6a78a05923b6ba17b97f1e860eb0bbd61ca
parent: 96a681496ac546f68efb3083a5a298788a2db69eb5e2b11647e1625e4aa03c72
content hash: 5e49fd1153c32b3c331342838ab7e02bdb73e6d3f2ae89a72dc12360baaf2ea2
signed: 2026-04-13T04:47:13.865Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf